High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.
You-Cheol HwangDavid A MorrowChristopher P CannonYuyin LiuRichard BergenstalSimon R HellerCyrus MehtaWilliam CushmanGeorge L BakrisFaiez ZannadWilliam B WhitePublished in: Diabetes, obesity & metabolism (2017)
Levels of hsCRP were associated with recurrent cardiovascular events in patients with type 2 diabetes and recent acute coronary syndrome, and this association appears to be independent of and additive to the achieved LDL-C level.